Home Title Index Topic Index Sources Directory News Releases Sources Calendar RSS Sources Select News RSS Feed

Biopharmaceuticals
AlterLinks Topic Index

  1. Anavex appoints contract research organizations to initiate Phase I/IIa clinical programs, regulatory strategies in Alzheimer's disease
    Sources News Release

    Resource Type: Article
    Published: 2010
    Anavex Life Sciences Corp signs a definitive master services agreement with Genesis BioPharma Group and ABX-CRO Advanced Pharmaceutical Services to begin clinical studies and regulatory filings for its lead compound for the treatment of Alzheimer#s.
  2. Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biotech Expert
    Media Profile in Sources

    Resource Type: Organization
  3. Stantec Inc.
    Media Profile in Sources

    Resource Type: Organization
  4. University of Ontario Institute of Technology (UOIT)
    Media Profile in Sources

    Resource Type: Organization

Sources-journalists use the sources website to find you


AlterLinks


© 2019. The information provided is copyright and may not be reproduced in any form or by any means (whether electronic, mechanical or photographic), or stored in an electronic retrieval system, without written permission of the publisher. The content may not be resold, republished, or redistributed. Indexing and search applications by Ulli Diemer and Chris DeFreitas.